☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Chemocentryx
ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis
January 20, 2022
OncoOne Entered into an Agreement with GenScript ProBio for the Manufacturing of Monoclonal Antibody Therapies Targeting oxMIF
November 18, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
